New Key Statistics Module, Z-Score and F-Score
OTCPK:XVIPF Key Ratios
| Market Cap $ M | 843.38 |
| Enterprise Value $ M | 824.35 |
| P/E(ttm) | 119.15 |
| PE Ratio without NRI | 119.15 |
| Forward PE Ratio | 77.34 |
| Price/Book | 4.07 |
| Price/Sales | 10.59 |
| Price/Free Cash Flow | 48.63 |
| Price/Owner Earnings | -- |
| Payout Ratio % | -- |
| Revenue (TTM) $ M | 89.00 |
| EPS (TTM) $ | 0.25 |
| Beneish M-Score | -2.83 |
| 10-y EBITDA Growth Rate % | -- |
| 5-y EBITDA Growth Rate % | -- |
| y-y EBITDA Growth Rate % | -2.00 |
| EV-to-EBIT | 92.10 |
| EV-to-EBITDA | 92.10 |
| PEG | -- |
| Shares Outstanding M | 31.50 |
| Net Margin (%) | 8.85 |
| Operating Margin % | 11.23 |
| Pre-tax Margin (%) | 11.44 |
| Quick Ratio | 3.10 |
| Current Ratio | 4.52 |
| ROA % (ttm) | 3.10 |
| ROE % (ttm) | 3.50 |
| ROIC % (ttm) | 3.51 |
| Dividend Yield % | -- |
| Altman Z-Score | 18.62 |
XVIPF Number of Guru Trades
XVIPF Volume of Guru Trades
Gurus Latest Trades with OTCPK:XVIPF
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
OTCPK:XVIPF is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Xvivo Perfusion AB Insider Transactions
No Available Data
News about OTCPK:XVIPF
Total 0- 1
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers